MORC3 and calcinosis: Factors associated with increased risk of calcinosis include younger age at disease onset, particularly disease onset in infancy, delay to diagnosis or delay to treatment initiation, more severe disease, prolonged disease duration, and presence of anti-nuclear matrix protein 2 (NXP2) autoantibodies [32, 33].